Fate Therapeutics Inc Shares Fall 9.4% Below Previous 52-Week Low - Market Mover
The shares fell 9.4% lower than its previous 52-week low of $19.62, with trading volume higher than its 30 day average
Jun 13, 2022 by Kwhen Finance Editors
Fate Therapeutics Inc (FATE) shares closed 9.4% lower than its previous 52 week low, giving the company a market cap of $1B. The stock is currently down 66.1% year-to-date, down 77.9% over the past 12 months, and up 558.1% over the past five years. This week, the Dow Jones Industrial Average fell 4.5%, and the S&P 500 fell 5.1%.
Trading Activity
- Trading volume this week was 37.3% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 2.1.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Fate Therapeutics Inc | -10.2 | -66.1 | -77.9 | -80.8 | -4.7 |
| Dow Jones Industrial Average | -2.8 | -12.8 | -7.3 | -16.2 | 0.4 |
| S&P 500 Index | -3.8 | -17.7 | -6.9 | -20.6 | -0.1 |
| Health Care | -1.7 | -12.4 | -1.6 | -14.8 | -0.9 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 269.4%
- The company's stock price performance over the past 12 months lags the peer average by 269.8%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Fate Therapeutics Inc | FATE | -8.2 | -66.1 | -77.9 | -80.8 | -4.7 |
| Peer Avg | N/A | 28.9 | -17.9 | -21.1 | -32.3 | 11.5 |
| Becton, Dickinson And Co. | BDX | 38.9 | 2.3 | 6.7 | -11.4 | 7.8 |
| Neurocrine Biosciences, Inc. | NBIX | 126.2 | 10.7 | -4.4 | -14.3 | 28.7 |
| Sarepta Therapeutics Inc | SRPT | -17.0 | -23.2 | -19.6 | -34.1 | 8.9 |
| PTC Therapeutics Inc | PTCT | -3.7 | -32.7 | -37.6 | -43.4 | -0.4 |
| Avidity Biosciences Inc | RNA | 0 | -46.6 | -50.5 | -58.1 | 12.5 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: